Results 111 to 120 of about 12,769 (188)

Correction: Real-World 6-Month Treatment Outcomes of Faricimab in Turkey: The FARTURK Study. [PDF]

Ophthalmol Ther
Çakır A, Akkan F, Kapran Z, Ünal M, Şerif N, Uzundede T, Karataş G, Öztürk M, Dündar H, Erakgün T, Alp MN, Koçak N, Saatci AO, Çetin EN, Durukan AH, Şahin M, Muhacir F, Yeşiltaş YS, Uyar OM, Emre S, Şekeroğlu MA, Önen M, Bulut M, Karalezli A, Kadayıfçılar S, Özdek Ş, Doğanay S, Kaya M, Öz Ö, Kaderli ST, Avcı R, Şermet F, Demirel S, Küçükerdönmez C, Yıldırım C, İpek ŞC, Ayhan Z, Altan T, Gürelik İG, Görgün E, Yenerel NM, Seymenoğlu G, Vural E, Sül S, Çıtırık M, Özdemir HB, Cömerter D, Karabaş VL, Özdemir H.   +48 more
europepmc   +1 more source

Response to letter regarding: "sarcopenia is a bad harbinger of cancer-related survival in rectal cancer". [PDF]

Ann Med
Rakici SY.
europepmc   +1 more source

The effect of GLP-1 receptor agonists on autophagy: insights gathered from research evaluating neurodegenerative disorders with these agents. [PDF]

Acta Neuropsychiatr
Sioufi MC, Heroiu I, Wong S, Le GH, Dri CE, Zheng YJ, Teopiz KM, Rhee TG, Lo HKY, Guillen-Burgos HF, McIntyre RS.   +10 more
europepmc   +1 more source

Correction to "Antifungal Efficacy of 3D-Cultured Palatal Mesenchymal Stem Cells and Their Secreted Factors against <i>Candida albicans</i>". [PDF]

ACS Infect Dis
Bicer M, Öztürk E, Sener F, Hakki SS, Fidan Ö.   +4 more
europepmc   +1 more source

Repurposing of semaglutide by targeting SIRT1 and TGF-β/Smad signaling in hepatic fibrosis. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Hawary OA, Wadie W, El-Said YAM, Hassan OF.   +3 more
europepmc   +1 more source

GLP-1 receptor agonists for treating obesity without diabetes: A systematic review and meta-analysis of economic evaluations. [PDF]

Diabetes Obes Metab
Dhippayom T, Meraz M, Lee H, Hur C, Inadomi JM, Veettil SK, Dunn JD, Chaiyakunapruk N.   +7 more
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists as a Potential Mitochondrial Modulation Therapy for Hidradenitis Suppurativa. [PDF]

Acta Derm Venereol
Hosseini A, Von Gunten S, Hunger RE, Zouboulis CC, Seyed Jafari SM.   +4 more
europepmc   +1 more source

Enhanced macromolecule bioavailability in rats and pigs using an in situ forming synthetic epithelial lining. [PDF]

J Control Release
Kanelli M, Yu AC, Susilo D, Petropulos O, Kadasia K, Sandoval L, Hudson MA, Sim D, Dial C, Mena MB, Liang J, Rivera-Delgado E, Sepich L, Hollfelder K, Wright J, von Erlach T, Hayward A, Gaspie KA, Barron SM, Pombo M, Basani RR, Lanchantin M, Lopes A, Pizzo S, Sethuraman V, Dhanda RK, Langer R, Traverso G.   +27 more
europepmc   +1 more source

Who Wins the Battle Against Obesity? A Network Meta-Analysis Comparing Tirzepatide and Semaglutide. [PDF]

J Diabetes
Bernardi JC, Cavalcante DVS, Huntermann R, Molinari ME, Zanon LZ, Khater J, Gomez VA, Fischer-Bacca CO.   +7 more
europepmc   +1 more source

Semaglutide Exacerbates Stunting in Growth-Impaired Juvenile Male Mice via Reduced Energy Metabolism. [PDF]

J Endocr Soc
Joly A, Rebiffé L, Dusabyinema Y, Dellinger J, Caillon E, Gauthier K, Leulier F, De Vadder F.   +7 more
europepmc   +1 more source